Latest News in the pharma Industry

Research & Development

Vectura expands capabilities to develop highly potent inhaled drugs

Vectura expands capabilities to develop highly potent inhaled drugs

14 Dec 2020

The expansion will enable the CDMO to widen the nature of inhaled drug development projects it can undertake for customers

Read more 
Catalent starts manufacture of Passage Bio's lead gene therapy products

Catalent starts manufacture of Passage Bio's lead gene therapy products

7 Dec 2020

The CDMO will provide packaging, labeling and distribution services through its FastChain demand-led supply offering

Read more 
Lonza expands development and manufacturing capabilities at Bend site

Lonza expands development and manufacturing capabilities at Bend site

30 Nov 2020

The company will invest in dedicated early-phase development and cGMP manufacturing to help customers rapidly advance challenging molecules

Read more 
AZ and Oxford COVID-19 vaccine brings end of pandemic a little closer

AZ and Oxford COVID-19 vaccine brings end of pandemic a little closer

24 Nov 2020

AZD1222 is 90% effective, cheap to produce and easy to store, distribute and administer

Read more 
Alvotech and Yangtze River forge biosimilar deal for Chinese market

Alvotech and Yangtze River forge biosimilar deal for Chinese market

24 Nov 2020

The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market

Read more 
Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective

Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective

17 Nov 2020

Data also show that mRNA-1273 remains stable at 2–8°, the temperature of a standard home or medical refrigerator, for 30 days.

Read more 
European Commission wraps up CureVac COVID-19 vaccine supply deal

European Commission wraps up CureVac COVID-19 vaccine supply deal

17 Nov 2020

Europeans set to benefit from the EC's authorization of COVID-19 candidate vaccine supply agreement, securing up to 405 million doses of CVnCoV

Read more 
Vibalogics establishes US presence with virotherapy facility in Boston

Vibalogics establishes US presence with virotherapy facility in Boston

16 Nov 2020

The specialist CDMO's $150 million 3-year investment plan will provide a complete suite of virotherapy services to support drug developers and their most "revolutionary" products.

Read more 
Novasep to develop and manufacture Handl Therapeutics' gene therapy product

Novasep to develop and manufacture Handl Therapeutics' gene therapy product

3 Nov 2020

The CDMO will supply drug substance and drug product to support Handl Therapeutics’ preclinical and clinical studies.

Read more 
Pill Connect secures £0.5m to take electronic smart pill bottle to commercial launch

Pill Connect secures £0.5m to take electronic smart pill bottle to commercial launch

3 Nov 2020

Device provides clinicians and trialists with comprehensive data on a patient's adherence pattern.

Read more 
Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine

Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine

28 Oct 2020

The companies anticipate first results of Phase I/II in early December 2020, to support the initiation of a pivotal Phase III study before the end of the year.

Read more 
Russia submits Sputnik V emergency use and prequalification application to WHO

Russia submits Sputnik V emergency use and prequalification application to WHO

27 Oct 2020

The Russian Federation has become one of the first countries to apply to the WHO for prequalification of its vaccine, Sputnik V, against the novel coronavirus infection.

Read more